Mutual Growth of Chinese and Western Medicine, Strengthening the Foundation and Cultivating VitalityNourishes Kidney Qi, Harmonizes Qi and Blood
The new GLP-1 ID protocol was developed in response to outcomes observed in a retrospective study published in Obesity Pillars (June 2025), which analyzed 1,131 patients treated through Ivms virtual GLP-1 program
This work is also limited by the demographics of our participants, who were predominantly white, tended to be young, and had high income and educational attainment
Access the complete GLP-1 Pipeline Update table for November 2024
Gmez-Vaquero, C
Its primarily used for specific autoimmune and neurological conditions, such as chronic inflammatory demyelinating polyneuropathy (CIDP), where the immune response is the direct cause of the disease